Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-24 @ 2:14 PM
Study NCT ID:
NCT05603195
Status:
COMPLETED
Last Update Posted:
2024-10-01
First Post:
2022-10-27
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Trial to Learn if Single Ascending Intravenous (IV) Doses of REGN7508 Are Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-17
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-27
First Submit QC Date:
None
Study First Post Date:
2022-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-10-01
Last Update Post Date Type:
ACTUAL